This sets unrealistic expectations for AI and leads to misuse. It also slows progress toward building new AI applications.
In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine ("Insilico"), in collaboration with NVIDIA, present a new large language ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results